Literature DB >> 1146654

Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover.

K Fuxe, L F Agnati, H Corrodi, B J Everitt, T Hökfelt, A Löfström, U Ungerstedt.   

Abstract

An ergolene derivative having a piperazine-phenyl side chain instead of a peptide side chain causes rotational behavior in experimental rats and appears to activate mainly limbic DA receptors when given in vivo, in contrast to amino acid ergot alkaloids, which appear to activate all DA receptors when given systemically. Theophyllamine and caffeine were found to cause considerable enhancement of the action of DA formed from DOPAP AND DA receptor agonists such as apomorphine, piribedil, and amino acid alkaloids on supersensitive DA receptors. Many DA receptor agonists such as apomorphine, piribedil, and CB 154 have in common the property to induce hypothermia in mice, an effect that may be related to actions on limbic DA receptors. Many DA receptors agonists such as apomorphine, piribedil, ergocornine, and CB 154 are able to block ovulation in immature rats treated with PMS. It is likely that this blockade is related to activation of a DA receptor in the median eminence controlling LRF secretion. DA receptor agonists antagonize sexual activity in the female rat, whereas DA receptor blocking agents enhance it. DA neurons may therefore subserve an inhibitory role in the control by hormones of sexual behavior. It is of considerable interest that there appear to exist inhibitory DA receptors with regard to both LRF secretion and sexual behavior.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1146654

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  7 in total

1.  Differential regional and kinetics effects of piribedil and bromocriptine on dopamine metabolites: a brain microdialysis study in freely moving rats.

Authors:  R Pagliari; L Peyrin; O Crambes
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.

Authors:  M K Menon; W G Clark; D T Masuoka
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

Review 3.  Bromocriptine in the treatment of parkinsonism.

Authors:  J D Parkes
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

Review 4.  On the role of dopamine in the pathophysiology of anorexia nervosa.

Authors:  V C Barry; H L Klawans
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

Review 5.  Pharmacology of bromocriptine in health and disease.

Authors:  A E Mehta; G Tolis
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

6.  Effects of 8-OH-DPAT, lisuride and some ergot-related compounds on the acoustic startle response in the rat.

Authors:  L Svensson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Effects of ET 495 (piribedil) on water intake in the rat: evidence for a dopaminergic involvement in thirst.

Authors:  C T Dourish; S J Cooper
Journal:  Ir J Med Sci       Date:  1978-08       Impact factor: 1.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.